Ignite Creation Date:
2024-05-06 @ 3:50 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02388412
Status:
UNKNOWN
Last Update Posted:
2016-02-23
First Post:
2015-03-04
Brief Title:
18F-NaF-PET for Identification of TCFA
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Study Overview
Official Title:
Evaluating the Diagnostic Accuracy of 18F-sodium Fluoride Positron Emission Tomography for Identification of High-risk Vulnerable Coronary Atherosclerotic Plaque in Patients With Coronary Artery Disease
Status:
UNKNOWN
Status Verified Date:
2016-02
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NaF-PET
Brief Summary:
Recently positron emission tomographyPET using 18F-Sodium fluoride NaF showed promising results for detecting vulnerable plaques in some pilot studies
In this study the investigators will evaluate the diagnostic accuracy of 18F-NaF PET for non-invasively detecting vulnerable plaque diagnosed by optical coherence tomography OCT
In this study the investigators will evaluate the diagnostic accuracy of 18F-NaF PET for non-invasively detecting vulnerable plaque diagnosed by optical coherence tomography OCT
Detailed Description:
It has been well known that mechanism of acute coronary syndrome is plaque rupture and occlusion of coronary artery by this plaque rupture Until now evaluation of vulnerable plaque have been mainly performed with invasive imaging modalities such as optical coherence tomography or intravascular ultrasound
Recently positron emission tomographyPET using 18F-Sodium fluoride NaF showed promising results for detecting vulnerable plaques in some pilot studies
In this study we will evaluate the diagnostic accuracy of 18F-NaF PET for non-invasively detecting vulnerable plaque diagnosed by optical coherence tomography OCT
Recently positron emission tomographyPET using 18F-Sodium fluoride NaF showed promising results for detecting vulnerable plaques in some pilot studies
In this study we will evaluate the diagnostic accuracy of 18F-NaF PET for non-invasively detecting vulnerable plaque diagnosed by optical coherence tomography OCT
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None